| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 424930440 | Streptococcus | 88 |
| 20080254010 | Controlling Clostridium difficile-Associated Disease in the Gastrointestinal Tract - This document provide materials and methods for treating patients infected with a spore-forming bacteria and materials and methods for preventing development of | 10-16-2008 |
| 20080286252 | Processing of Natural Polysaccharides by Selected Non-Pathogenic Microorganisms and Methods of Making and Using the Same - The present invention includes compositions and methods of making and using a dietary supplement manufactured from one or more natural polysaccharides previously incubated with a probiotic bacteria in a bioreactor system, wherein the bacteria process the polysaccharides and the resulting processed polysaccharide are provided in the nutritional supplement. | 11-20-2008 |
| 20080311097 | Treatment of Ibd and Ibs Using Both Probiotic Bacteria and Fermented Cereal as Treatment Effectors - The invention covers a novel treatment strategy that considerably improves conventional probiotic treatments of inflammatory bowel diseases, irritable bowel syndrome and other gastrointestinal disorders. Both probiotic microorganisms and the carrier of the probiotic microorganisms in form of a fermented cereal gruel are used as treatment effectors. Phospholipids may also be an effecter. The novel treatment strategy is capable of removing the symptoms of inflammatory bowel diseases regardless of a mild, moderate or severe stage of the disease. | 12-18-2008 |
| 20090087418 | Method for the Preparation of Anallergic Probiotic Bacterial Cultures and Related Use - The aim of the present invention is a method for the preparation of anallergic probiotic bacterial cultures. | 04-02-2009 |
| 20090232785 | Cosmetic and/or dermatological composition for prevention and/or treatment of sensitive or dry skin - The invention relates to a cosmetic and/or dermatological topical composition, of particular use for the prevention al and/or treatment of sensitive and/or dry skin, comprising an effective amount of at least one particularly probiotic microorganism and/or a fraction or metabolite thereof in combination with an effective amount of at least one polyunsaturated fatty acid and/or polyunsaturated fatty acid ester and/or a salt or derivative thereof in a physiologically-acceptable vehicle. | 09-17-2009 |
| 20090246184 | DELIVERY VEHICLE FOR PROBIOTIC BACTERIA COMPRISING A DRY MATRIX OF POLYSACCHARIDES, SACCHARIDES AND POLYOLS IN A GLASS FORM AND METHODS OF MAKING SAME - The disclosure relates to a solid glass matrix of polysaccharide, saccharides and polyols as delivery vehicle for preservation and post gastric administration of a probiotic. The delivery vehicle is capable of releasing the probiotic at their site of action. The present invention further includes methods of making and using the solid glass matrix delivery vehicle of the invention. | 10-01-2009 |
| 20090263366 | Effects of probiotics on humans and animals under environmental or biological changes - An exemplary embodiment providing one or more improvements includes probiotic compositions comprising probiotic microorganisms with dried vegetable, fruit, cereal, or herb powder. Feeding human or animals either having biological or environmental changes with probiotic compositions has a positive effect in relieving the changes. Positive effects has been demonstrated in humans, dogs, and fish. | 10-22-2009 |
| 20090304655 | INFANT FORMULA WITH PROBIOTICS - The invention relates to an infant formula comprising a source of protein in an amount of not more than 2.0 g/100 kcal, a source of lipids, a source of carbohydrate and a probiotic wherein the probiotic is present in an amount equivalent to between 10 | 12-10-2009 |
| 20100015109 | Composition for High-ORAC Value Dietary Supplement - A dietary supplement composition having an ORAC value in excess of at least about 2,500 and which can be readily consumed in a small quantity is provided for supplementing an individual's daily intake. The dietary supplement composition suitably includes organic and/or vegan ingredients and can be consumed in quantities of as little as about 1 tablespoon to provide an amount of antioxidants equivalent to at least the minimum recommended daily intake of five to nine servings of fruits and/or vegetables. | 01-21-2010 |
| 20100015110 | FERMENTED MILK FOR SKIN IMPROVEMENT AND/OR TREATMENT AND PROCESS FOR PRODUCING THE SAME - The present invention provides a composition and fermented milk, which is derived from natural product, is highly safe, exhibits improvement effect and/or therapeutic effect on skin, and comprises fermented lactic acid bacteria excellent in manufacturability. Disclosed are: use of | 01-21-2010 |
| 20100074877 | COMPOSITION FOR IMPROVING SKIN QUALITY AND A PROCESS FOR PREPARING THE SAME - The present invention relates to a composition including, as active substance, a mixture of at least one polyunsaturated fatty acid, different from polyunsaturated fatty acid derived from milk, polyphenols, milk proteins and lactic bacteria, and the composition having a water content of at least 50% by weight; and wherein the polyunsaturated fatty acid presents an increased bioavailability compared with the one of the polyunsaturated fatty acid alone. | 03-25-2010 |
| 20100092440 | COMPOSITION FOR THE ADMINISTRATION OF BIOLOGICALLY ACTIVE PRINCIPLES IN GYNAECOLOGIC AND RECTAL FIELD AND USES THEREOF - The present invention relates to a composition for the administration of biologically active substances in a gynaecologic and rectal ambit, as well as the uses of said composition. Said composition presents particularly favourable technological and stability characteristics of the end product, above all with regard to the viscosity after the dissolution/resuspension of the same in a hydrophilic liquid medium which allows a better adhesion and a direct contact from bacteria to the treated mucosae. Said composition includes a specific viscosizing agent selected from the group of the gums, which can play an important prebiotic function by contributing in a significant way to the correct growth and colonization of the probiotic culture, thus forming a perfect symbiotic system. | 04-15-2010 |
| 20100135971 | PROBIOTICS IN A PRE- AND/OR POST SURGICAL ENVIRONMENT - The present invention relates generally to the field of nutrition, more particularly to the use of probiotics in nutrition. In particular the present invention relates to the use of a probiotic or of a mixture of probiotics in the manufacture of a nutritional composition or a medicament to act the colon in a pre- or post surgical environment. | 06-03-2010 |
| 20100150891 | MEDICINAL COMPOSITION, FOOD OR DRINK HAVING EFFECT OF ENHANCING PARASYMPATHETIC NERVOUS ACTIVITY - It is intended to provide a safe composition for treating a disease or condition relating to autonomic nervous activity which has an autonomic nervous control effect; in particular, an effect of enhancing parasympathetic nervous activity. Thus, a medicinal composition, a food or a drink containing L-phenyl lactic acid and/or D-phenyl lactic acid and having an autonomic nervous control effect is provided. | 06-17-2010 |
| 20100166721 | PROBOTIC COMPOSITIONS AND USES THEREOF - The present application relates to a probiotic composition comprising a probiotic bacteria. The composition is particularly useful as a food supplement for normalizing the gastro-intestinal flora. The probiotic bacteria present in the composition contain species of | 07-01-2010 |
| 20100189702 | COMPOSITIONS AND METHODS FOR RESTORING BACTERIAL FLORA - The invention provides compositions, kits, and methods for providing or restoring beneficial bacteria to a subject. The compositions and kits optionally include food or nutrients to promote growth and proliferation of the bacteria in the subject or an antimicrobial agent to reduce the presence of undesirable or pathogenic microbes in the subject. | 07-29-2010 |
| 20100266560 | AGENT STABILISATION PROCESS AND PRODUCT - The invention relates to a composition and method of manufacture including a substrate coated with a biopolymer and aqueous biological gel and subsequently coated with at least one desiccation agent. The resulting composition is dry to touch, has a low water activity and stabilises the biological material for storage over at least one month at ambient temperatures. | 10-21-2010 |
| 20100284979 | Modulation of Tissue Fatty Acid Composition of a Host by Human Gut Bacteria - The current invention provides use of a CLA-producing bacterium for the in vivo conversion in the gut of polyunsaturated fatty acids to CLA. The CLA-producing bacterium is selected from one or more of the group consisting of propionibacteria, lactobacilli, lactococci and streptococci, and bifidobacteria. | 11-11-2010 |
| 20100291049 | ANTI-WRINKLE AGENT - The invention provides an anti-wrinkle agent which has an excellent effect of inhibiting the formation of wrinkles and excellent safeness. | 11-18-2010 |
| 20100291050 | Nutritional Compositions for Reducing Oxidative Damage - A nutritional composition for reducing oxidative damage and lipid peroxidation in humans, while allowing for the oxidative reactions necessary to sustain vital biological functions. The nutritional compositions comprise adaptogens comprising astragalus root, ashwagandha root, cordyceps, holy basil leaf, maca root, reishi mushrooms, schizandra, and suma root; superfoods comprising acerola, camu-camu, pomegranate, bilberry, blueberry, Goji berries, Acai, maitake, citrus bioflavonoids, rose hips, and Gingko biloba; probiotics comprising bifidobacterium longum, lactobacillus acidophilus, lactobacillus acidophilus DDS-1, lactobacillus bulgaricus, lactobacillus casei, and streptococcus thermophilus; and enzymes comprising amylase, papain, cellulose, lactase, lipase, protease, and bromelain. The nutritional compositions may also be provided as a meal replacement and further comprise one or more plant products, algae, vitamins, minerals, protein and MSM. | 11-18-2010 |
| 20110002900 | MEDIUM CHAIN DICARBOXYLIC ACIDS, THEIR DERIVATES AND METABOLIC DISORDERS - The present invention relates in general to medium chain dicarboxylic acids, their derivatives and their uses. In particular, the present invention relates to a composition comprising medium chain dicarboxylic acids and to the use of medium chain dicarboxylic acids and their derivatives for the preparation of products to treat or prevent metabolic disorders. The composition of the present invention can particularly well be used to treat or prevent hyperglycemia, for example diabetes. | 01-06-2011 |
| 20110020302 | NATURAL PRESERVATIVE BLEND - A composition to be used as a natural preservative is provided. The composition comprises 1.0 to 20% w/w one or more naturally occurring substances containing salicylate, 0.1 to 20% w/w one or more species of lonicera, 0.1 to 80% w/w one or more | 01-27-2011 |
| 20110020303 | NOVEL USE OF PROBIOTICS - The invention relates to the use of probiotics in the manufacture of a composition for enhancing a metabolic profile in a subject. The probiotics are capable of preventing and treating diseases or disorders associated with an abnormal metabolic profile, especially a lipid profile by normalizing the profile. The probiotics are particularly effective in down-regulating levels of lysophosphatiydylcholines (LysoPCs) and ceramides. | 01-27-2011 |
| 20110091431 | COMPOSITIONS AND METHODS COMPRISING PEDIOCOCCUS FOR REDUCING AT LEAST ONE SYMPTOM ASSOCIATED WITH AUTISM SPECTRUM DISEASE IN A PERSON DIAGNOSED WITH AN AUTISM SPECTRUM DISEASE - Compositions, methods, etc., comprising | 04-21-2011 |
| 20110104134 | NOVEL LACTIC ACID BACTERIUM HAVING HIGH IMMUNOGLOBULIN-A-INDUCING ABILITY - A novel lactic acid bacterium strain is found, which has a high IgA production-inducing ability and a high immunostimulating activity, and belongs to the genus | 05-05-2011 |
| 20110110904 | NUTRITIONAL COMPOSITION CONTAINING OLIGOSACCHARIDE MIXTURE - A nutritional composition for administration to an infant which composition comprises, on a dry matter basis, from 2.5 to 15.0 wt % of an oligosaccharide mixture consisting of N-acetylated oligosaccharide(s), galacto-oligosaccharide(s) and sialylated oligosaccharide(s) with the proviso that the composition comprises at least 0.02 wt % of an N-acetylated oligosaccharide, at least 2.0 wt % of a galacto-oligosaccharide and at least 0.04 wt % of a sialylated oligosaccharide and that the N-acetylated oligosaccharide(s) comprise 0.5 to 4.0% of the oligosaccharide mixture, the galacto-oligosaccharide(s) comprise 92.0 to 98.5% of the oligosaccharide mixture and the sialylated oligosaccharide(s) comprise 1.0 to 4.0% of the oligosaccharide mixture. The composition is useful for administration to an infant in the first six months of life to reduce the risk of obesity later in life. | 05-12-2011 |
| 20110123501 | GUT FLORA AND WEIGHT MANAGEMENT - The present invention relates to supporting weight management, weight loss and/or to the prevention and/or treatment of metabolic disorders. In particular the present invention relates to preventing and/or treating metabolic disorders by modulating, in particular reducing the amount of proteobacteria and/or deferribacteres in the gut. One embodiment of the present invention relates to the use of a primary composition comprising an agent that reduces the amount of proteobacteria, preferably gamma-proteobacteria, even more preferred enterobacteria; and/or deferribacteres in the gut for the preparation of a composition to treat or prevent metabolic disorders, to support weight loss and/or to support weight management. | 05-26-2011 |
| 20110129451 | METHOD FOR DECREASING BORBORYGMI BY ADMINISTERING A BIFIDOBACTERIUM BACTERIA - The present invention relates to a method for decreasing borboiygmi in a subject by administering a probiotic, preferably a bacteria of the | 06-02-2011 |
| 20110150851 | NUTRITIONAL COMPOSITION FOR INFANTS DELIVERED VIA CAESAREAN SECTION - The present invention relates to compositions to be administered to infants delivered via caesarean section and in particular to a product comprising inactivated cells and/or bacterial cell fragments of Gram-negative bacteria and of optionally inactivated Gram-positive bacteria. Thereby it is possible to stimulate a fast colonisation of the intestinal microbiota of said infants. | 06-23-2011 |
| 20110189144 | Compositions Comprising Lactobacillus Casei for Improving Resistance to Common Infectious Diseases - The use of a | 08-04-2011 |
| 20110236358 | COMPOSITION COMPRISING ISOFLAVONES - A composition comprising at least one isoflavone, phloridzin and one or more probiotics. A composition as described herein is also provided for internal use as a natural alternative to hormone replacement therapy and for treating disorders such as menopause and correlated symptoms, alcoholism, stress, insomnia, obesity and cellulite. | 09-29-2011 |
| 20110262409 | COMPOSITION COMPRISING A COMBINATION OF AN ELDER EXTRACT AND A STRAIN OF L. PARACASEI, L. CASEI, L. BULGARICUS OR S. THERMOPHILUS - The invention relates to a composition comprising a combination of an elder extract ( | 10-27-2011 |
| 20110286986 | LACTOFERRIN AND ANGIOGENIN COMPOSITIONS AND USES THEREOF - Compositions are described which contain lactoferrin and angiogenin. The described compositions are useful in treatment of a variety of conditions, particularly in promoting bone health and relief of menopausal symptoms. | 11-24-2011 |
| 20110300117 | Novel Lactobacillus Strain, Composition and Use Thereof for Improving the Syndrome of Diabetes and Complication Thereof - The invention relates to a composition for improving the syndrome of diabetes and complication thereof. The composition comprises an effective amount of | 12-08-2011 |
| 20120009163 | MEANS AND METHODS FOR ACTIVATING VAGUS NERVE - An object of the present invention is to provide an effective means and method for activating vagal afferent nerve. The present invention provides a vagus nerve activator comprising bacterial cells and/or a treated product of a lactic acid bacteria as active ingredient(s). | 01-12-2012 |
| 20120027734 | METHOD FOR ALLEVIATING INTESTINAL PROBLEMS AND NOVEL BACTERIAL STRAINS THEREFOR - The present invention relates to butyrate producing bacterial strains related to the species Buty{acute over (η)}coccus pullicaecorum to be used in the prevention and/or treatment of intestinal health problems. The present invention therefore provides methods and compositions that overcome the problems associated with the currently used methods for administering butyric acid in the treatment of intestinal health problems in humans and/or animals. | 02-02-2012 |
| 20120027735 | SYMBIOTIC MAPLE PRODUCT COMPOSITIONS AND METHODS - The present invention relates to novel maple product compositions. In particular, the present invention relates to new compositions comprising maple sap, maple concentrate, maple syrup or diluted maple syrup, and probiotics, prebiotics or combinations thereof. The present invention also discloses methods for the production of maple based products, including functional drinks, comprising a composition comprising maple sap, maple concentrate, maple syrup or dilutated maple syrup, and probiotics, prebiotics or combinations thereof, as a vehicle for the delivery of probiotics and prebiotics to the gastrointestinal tract. | 02-02-2012 |
| 20120034198 | CARRIERS FOR STORAGE AND DELIVERY OF BIOLOGICS - Processes and formulations for the administration and storage of dried microorganisms are disclosed. Microbial based products containing prebiotic formulations for administration and for storage of microorganisms are disclosed. These prebiotic formulations can act both for administration into an animal or human subject and act as to preserve or store the dried microorganisms. | 02-09-2012 |
| 20120039860 | COMPOSITIONS AND METHODS FOR IMPROVED ORAL HEALTH - Compositions and methods for preventing and treating illnesses associated with oral health are provided. In a general embodiment, the compositions and methods of the present disclosure can improve oral health by reducing the incidence of aspiration pneumonia, community-acquired pneumonia and nosocomial pneumonia, allowing for less gingivitis and plaque, and providing improved tongue flora. By utilizing probiotics naturally present in the oral cavity or gastrointestinal tract, the compositions and methods in embodiments of the present disclosure can reduce anaerobic gram-negative bacilli and increase the presence of the normal flora. By preventing and treating problems associated with oral health in a patient, subsequent health problems can be prrevented or mitigated, which can result in reduced health care costs for the patient in the future. | 02-16-2012 |
| 20120058095 | OILY SUSPENSION CONTAINING PROBIOTIC BACTERIA FOR PAEDIATRIC USES - The present invention refers to an oily suspension containing probiotic bacteria, particularly suitable for paediatric use. | 03-08-2012 |
| 20120064051 | INFANT AND YOUNG CHILDREN FEEDING FORMULA COMPRISING PROBIOTICS FOR INFANTS AND YOUNG CHILDREN - The present invention relates to the field of infant and young children nutrition. In particular, the present invention relates to infant and young children feeding formulas comprising probiotic micro-organisms to be administered to infants and young children older than 6 months. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example. | 03-15-2012 |
| 20120107287 | SPECIALIZED MEDICAL NUTRITION FOR SURGICAL AND TRAUMA PATIENTS CONTAINING PROBIOTICS - The present invention relates to the field of specialized nutritional compositions. In particular, the present invention provides nutritional compositions for providing complete nutrition to hospitalized patients comprising probiotic micro-organisms. Such probiotic micro-organisms may be non-replicating micro-organisms, such as bioactive heat-treated probiotic micro-organisms, for example. | 05-03-2012 |
| 20120114621 | DELIVERY VEHICLE FOR PROBIOTIC BACTERIA COMPRISING A DRY MATRIX OF POLYSACCHARIDES, SACCHARIDES AND POLYOLS IN A GLASS FORM AND METHODS OF MAKING SAME - The disclosure relates to a solid glass matrix of polysaccharide, saccharides and polyols as delivery vehicles for preservation and post gastric administration of a probiotic. The delivery vehicle is capable of releasing the probiotic at their site of action. The present invention further includes methods of making and using the solid glass matrix delivery vehicle of the invention. | 05-10-2012 |
| 20120121561 | DRY WHOLE MILK PREPARATIONS CONTAINING PROBIOTIC MICRO-ORGANISMS - The present invention relates to the field of nutrition for young children. In particular, the present invention relates to dry whole milk preparations comprising probiotic micro-organisms to be administered to young children older than 12 months. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example. | 05-17-2012 |
| 20120121562 | NUTRITIONAL COMPOSITION FOR BREAST-FED INFANTS OR PETS WITH PROBIOTICS AND SELECTED NUTRIENTS - The present invention relates to a nutritional supplement compositions for breast-fed infants or pets which comprise at least one probiotic and at least one nutrient. The compositions are aimed at preserving exclusive breast feeding in infants. The compositions of the invention are also for use in improving the health of breast-fed infants. A method of preparing a nutritional supplement composition for breast-fed infants is also provided. | 05-17-2012 |
| 20120128644 | Use of Bacteria to Treat and Prevent Respiratory Infections - The invention provides methods for treating respiratory infections by administering compositions comprising one or more isolated, non-pathogenic, hydrogen peroxide-producing bacterial species or strains to the mouth, oropharynx, larynx, nasal cavity, fauces of a subject. | 05-24-2012 |
| 20120134973 | NOVEL USE OF PROBIOTICS - The present invention relates to use of a probiotic to normalize abnormal inflammation markers. The present invention also relates to use of a probiotic for preventing and/or treating low-grade inflammation. Further, the present invention relates to use of a probiotic for preventing and/or treating disorders and/or diseases relating to low-grade inflammation. | 05-31-2012 |
| 20120141443 | SHORT-TIME HIGH TEMPERATURE TREATMENT GENERATES MICROBIAL PREPARATIONS WITH ANTI-INFLAMMATORY PROFILES - The present invention generally relates to the field of bacteria. In particular, the present invention concerns “short time high temperature” treated probiotics and/or dairy starter cultures and applications of these bacteria. One embodiment of the present invention relates to “short-time high temperature” treated probiotics and/or dairy starter cultures and their use to prepare compositions to treat or prevent inflammatory disorders. | 06-07-2012 |
| 20120141444 | NUTRITIONALLY BALANCED STANDARD TUBE FEEDING FORMULA CONTAINING PROBIOTICS - The present invention relates to the field of enteral nutrition to be administered via tube feeding. In particular, the present invention provides tube feeding formulas for complete nutrition comprising probiotic micro-organisms. Such probiotic micro-organisms may be non-replicating micro-organisms, such as bioactive heat-treated probiotic micro-organisms, for example. | 06-07-2012 |
| 20120141445 | NUTRITION FOR IMPROVING MUSCLE STRENGTH IN ELDERLY - The invention pertains to a composition for stimulating muscle strength in elderly, comprising whey protein, free BCAA and probiotic bacteria, wherein the composition comprises one or more free BCAAs selected from the group consisting of leucine, isoleucine and valine, and at least 50 g whey protein per 100 g dry weight of the total composition. Also, the invention pertains to a composition additionally comprising one or more dietary fibers selected from the group of pectins, pectates, alginates, fructans, fructooligosaccharides, indigestible dextrins, galactooligosaccharides, xylooligosaccharides, arabinooligosaccharides, glucooligosaccharides, mannooligosaccharides and fucooligosaccharides, and to the use of such composition in dietary management of malnutrition of elderly. | 06-07-2012 |
| 20120183513 | Lactobacillus Supplement for Alleviating Type I Diabetes | 07-19-2012 |
| 20120183514 | INFANT CEREAL COMPRISING NON-REPLICATING PROBIOTIC MICROORGANISMS - The present invention relates to the field of infant cereals. In particular, the present invention relates to the field of infant cereals that can be used to strengthen the immune system of the infant and/or that can be used to treat or prevent inflammatory disorders. For example these benefits can be provided by probiotic micro-organisms. An embodiment of the present invention relates to an infant cereal comprising non-replicating probiotic-micro-organisms, for example bioactive heat treated probiotic micro-organisms. | 07-19-2012 |
| 20120183515 | ORAL NUTRITIONAL SUPPLEMENT COMPRISING PROBIOTICS - The present invention relates to the field of nutrition. In particular, the present invention relates to the field of oral supplements. One embodiment of the present invention relates to the field of oral supplements comprising probiotics and/or bioactive non-replicating probiotics, for example heat treated probiotics. | 07-19-2012 |
| 20120189598 | ORAL NUTRITIONAL SUPPLEMENT FOR CHILDREN COMPRISING PROBIOTICS - The present invention relates to the field of nutrition for children. In particular, the present invention relates to the field of oral supplements. One embodiment of the present invention relates to the field of oral supplements comprising probiotics and/or bioactive non-replicating probiotics, for example heat treated probiotics. | 07-26-2012 |
| 20120195867 | PROBIOTIC CONTAINING MODULES FOR TUBE FEEDING - The present invention relates to the field of enteral nutrition to be administered via tube feeding. In particular, the present invention provides tube feeding modules comprising probiotic micro-organisms. Such probiotic micro-organisms may be non-replicating micro-organisms, such as bioactive heat-treated probiotic micro-organisms, for example. | 08-02-2012 |
| 20120237489 | SUPPOSITORY FOR RECTAL, VAGINAL OR URETHRAL ADMINISTRATION CONTAINING A PROBIOTIC, AN ANTIBIOTIC AND AN UNSATURATED NON-ESTERIFIED FATTY ACID - A suppository is provided for rectal, vaginal or urethral administration. A method also is provided for the preparation of a suppository for rectal, vaginal or urethral administration. The method uses at least one unsaturated, non-esterified fatty acid in a composition containing a probiotic and an antibiotic. | 09-20-2012 |
| 20120288483 | DELIVERY VEHICLE FOR PROBIOTIC BACTERIA COMPRISING A DRY MATRIX OF POLYSACCHARIDES, SACCHARIDES AND POLYOLS IN A GLASS FORM AND METHODS OF MAKING SAME - The disclosure relates to a solid glass matrix of polysaccharides, monossaccharides or disaccharides in combination with polyols as delivery vehicles for preservation and post gastric administration of a probiotic. The delivery vehicle is capable of releasing the probiotic at their site of action. The present invention further includes methods of making and using the solid glass matrix delivery vehicle of the invention. | 11-15-2012 |
| 20120294839 | Prosthetic Apparatus - Prosthetic apparatuses with probiotic microorganisms to control colonization of pathogenic bacteria are disclosed. The prosthetic apparatus may include a first portion having a first mating surface, a second portion having a second mating surface that conforms to the first mating surface, and at least one strain of probiotic microorganisms retained between the first and second mating surfaces prior to implantation of the prosthetic apparatus. | 11-22-2012 |
| 20120294840 | Use Of Purified 2'-Fucosyllactose, 3-Fucosyllactose and Lactodifucotetraose as Prebiotics - The invention provides compositions and methods for utilizing synthetic human milk oligosaccharides as prebiotics. | 11-22-2012 |
| 20130071367 | ANIMAL FEED FOR CALVES FOR CONDITIONING THE INTESTINAL FLORA - The present invention is directed to a animal feed for calves comprising calf-specific bacteria, optionally lipids, proteins, vitamins and/or mineral materials for conditioning of the intestinal flora in calves, and thus, for prophylaxis and/or treatment of diarrhea in calves. | 03-21-2013 |
| 20130084271 | Probiotic composition for pets and method of providing the same - A probiotic composition, delivery device, method of forming, and a method for delivery are disclosed. The composition may be in the form of a spray, mist, film, or the like suitable for use with any pre-formulated pet food product, whether in solid or liquid form, and further to the use of the spray directly on the coat or skin of an animal. The probiotic spray may also be applied directly into a cavity of the animal, for example into its mouth or nasal passages. The probiotic composition provides multiple strains or species of viable bacteria that provide health benefits when ingested, and is shown herein primarily for consumption by or use on/in animals, though the invention is not limited in any way to use strictly for animal intake, but may also be suitably used for human ingestion. | 04-04-2013 |
| 20130095086 | COMPOSITION AND USE OF LACTOBACILLUS PARACASEI STRAIN GMNL-133 IN TREATING ATOPIC DERMATITIS OR OTHER ALLERGIC DISEASES - An isolated | 04-18-2013 |
| 20130121976 | Lactic Acid Bacteria for Coeliac Disease - The present invention discloses strains of | 05-16-2013 |
| 20130195821 | Treatment of IBD and IBS Using Both Probiotic Bacteria and Fermented Cereal as Treatment Effectors - The invention covers a novel treatment strategy that considerably improves conventional probiotic treatments of inflammatory bowel diseases, irritable bowel syndrome and other gastrointestinal disorders. Both probiotic microorganisms and the carrier of the probiotic microorganisms in form of a fermented cereal gruel are used as treatment effectors. Phospholipids may also be an effector. The novel treatment strategy is capable of removing the symptoms of inflammatory bowel diseases regardless of a mild, moderate or severe stage of the disease. | 08-01-2013 |
| 20130209429 | Modulation of Tissue Fatty Acid Composition of a Host by Human Gut Bacteria - The current invention provides use of a CLA-producing bacterium for the in vivo conversion in the gut of polyunsaturated fatty acids to CLA. The CLA-producing bacterium is selected from one or more of the group consisting of propionibacteria, lactobacilli, lactococci and streptococci, and bifidobacteria. | 08-15-2013 |
| 20130224165 | DRINKING YOGHURT PREPARATIONS CONTAINING NON-REPLICATING PROBIOTIC MICRO-ORGANISMS - The present invention relates to the field of drinkable yoghurt compositions. In particular, the present invention provides drinkable yoghurt compositions comprising non-replicating probiotic micro-organisms. These non-replicating probiotic micro-organisms may be bioactive heat treated probiotic micro-organisms, for example. The present invention also relates to health benefits provided by these non-replicating probiotic micro-organisms. | 08-29-2013 |
| 20130224166 | POWDERED CEREAL COMPOSITIONS COMPRISING NON-REPLICATING PROBIOTIC MICROORGANISMS - The present invention relates to the field of powdered cereal compositions to be reconstituted in milk, infant formula or water. In particular, the present invention relates to powdered cereal compositions to be administered to infants or young children. The powdered cereal compositions may be used to strengthen the immune system and/or to treat or prevent inflammatory disorders. For example these benefits can be provided by probiotic micro-organisms. An embodiment of the present invention relates to a powdered cereal composition comprising non-replicating probiotic-micro-organisms, for example bioactive heat treated probiotic micro-organisms. | 08-29-2013 |
| 20130224167 | NON-REPLICATING PROBIOTIC BACTERIA AND PREVENTION OR TREATMENT OF INFECTIONS TO REDUCE ABSENCE FROM SCHOOL OR DAYCARE - The present invention relates to non-replicating probiotic micro-organisms and their health benefits. In particular, the present invention provides a means to help parents to protect their children from infections. The subject matter of the present inventions allows it to reduce absence from school or daycare. One embodiment of the present invention relates to a composition comprising non-replicating probiotic micro-organisms for use in the prevention or treatment of infections in children to reduce absence from school or daycare. | 08-29-2013 |
| 20130302296 | Treatment and Prophylaxis for Obsessive Compulsive Disorder - An embodiment is a method of preventing, mitigating or treating Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) that includes administering an effective amount of a medicament comprised of | 11-14-2013 |
| 20140127176 | ORAL BACTERIA AND USES THEREOF - The present invention relates to compositions and methods for preventing and treating periodontitis and other conditions. In particular, the present invention relates to oral bacteria for use in treating and preventing diseases and conditions. | 05-08-2014 |
| 20140140970 | Use of Secretor, Lewis and Sialyl Antigen Levels in Clinical Samples as Predictors of Risk for Disease - An individual at risk for necrotizing enterocolitis and related disorders can be identified by measuring the level of at least one secretor antigen in a biological sample from the individual and comparing the measured level of the at least one secretor antigen to a predetermined value or a predetermined range of values. Among the secretor antigens which can be measured are: the H-1, H-2, Lewis | 05-22-2014 |
| 20140140971 | COMPOSITIONS COMPRISING ALKALINE SPHINGOMYELINASES FOR USE AS A DIETETIC PREPARATION, FOOD SUPPLEMENT OR PHARMACEUTICAL PRODUCT AND METHODS FOR USING THEM - The invention relates to a composition which, depending on the user, may be taken as a nutritional, dietetic or strictly therapeutic preparation, comprising as its active substance alkaline sphingomyelinase which is capable of preventing or treating various pathological conditions including cancerous processes, inflammatory processes of the intestine, hypercholesterolaemia and infections with | 05-22-2014 |
| 20140147426 | ANTICARIES COMPOSITIONS AND PROBIOTICS/PREBIOTICS - The present invention discloses different specific bacterial strains isolated from individuals without caries which are characterised in that they present inhibitory activity against cariogenic organisms. The invention also discloses a process for isolating said strains, as well as bioactive peptides, such as anti-microbial peptides of human and bacterial origin, which also show anti-cariogenic activity. Moreover, the present invention also discloses pharmaceutical and/or probiotic/prebiotic compositions, functional foods, mouthwashes, toothpaste, chewing gum, etc., that comprise at least one of the strains and/or at least one of the bioactive peptides described in the invention, or a combination thereof, which are useful in the treatment and/or prevention of infectious diseases of the buccal cavity, preferably caries. | 05-29-2014 |
| 20140161780 | COMPOSITIONS AND METHODS FOR AUGMENTING KIDNEY FUNCTION - A protein-rich nutritional food product composed of a probiotic and an edible isolated protein. The probiotic component may comprise | 06-12-2014 |
| 20140161781 | ZINC-ENRICHED BIOMASS, METHOD FOR THE PREPARATION THEREOF AND PRO-BIOTIC, COSMETIC, DIETARY AND NUTRACEUTIC PRODUCTS COMPRISING THE SAME - The invention relates to a zinc-enriched biomass comprising living or subsequently killed micro-organisms, selected from the group consisting of | 06-12-2014 |
| 20140248246 | EDIBLE WEB COMPRISING MICROORGANISMS - The present invention relates to edible webs comprising microorganisms, such as probiotics. In particular, the present invention relates to an edible web having microorganisms, such as bacteria, probiotic bacteria, bacteriophages or viruses printed thereon, e.g. by the use of inkjet printing. In addition the invention relates to methods of producing such edible webs, to various products comprising the edible webs as well as to use of the edible webs comprising microorganisms. | 09-04-2014 |
| 20140271585 | TREATMENT OF CHRONIC IDIOPATHIC EMESIS IN FELINES AND CANINES - Use of a probiotic for the treatment of chronic idiopathic emesis in canines and felines. | 09-18-2014 |
| 20140294789 | GALACTOOLIGOSACCHARIDES FOR PREVENTING INJURY AND/OR PROMOTING HEALING OF THE GASTROINTESTINAL TRACT - Disclosed are nutritional compositions including galactooligosaccharides that can be administered to individuals including preterm infants, infants, toddlers, children, and adults for preventing injury and/or improving the healing of the gastrointestinal tract. Additional suitable methods of using the nutritional compositions including the galactooligosaccharides are also disclosed. | 10-02-2014 |
| 20140301994 | PROBIOTIC STICK FORMULATION FOR SKIN MAINTENANCE AND METHODS OF USE - The invention relates to an anhydrous mixture of biologically active probiotic bacteria for topical administration and methods of making thereof. The mixture of the invention is used for hydrating the skin, reducing and preventing fine lines and wrinkles, treating acne and decreasing skin inflammation. | 10-09-2014 |
| 20140335065 | HUMAN MILK OLIGOSACCHARIDES FOR PREVENTING INJURY AND/OR PROMOTING HEALING OF THE GASTROINTESTINAL TRACT - Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to individuals including preterm infants, infants, toddlers, children, and adults for preventing injury and/or improving the healing of the gastrointestinal tract. Additional suitable methods of using the nutritional compositions including the human milk oligosaccharides are also disclosed. | 11-13-2014 |
| 20140356337 | COMPOSITION COMPRISING AN ACTIVATED MICROBIAL BIOMASS - The present invention relates to a composition comprising a substrate capable of being evenly coated with a microbial biomass, wherein said biomass represents from 10% to 30% by dry matter of the total dry matter of the coated substrate. It also relates to a method for preparing said composition and to a starter fermentation activator and to a probiotic comprising said composition. | 12-04-2014 |
| 20150079055 | USE OF SECRETOR, LEWIS AND SIALYL ANTIGEN LEVELS IN CLINICAL SAMPLES AS PREDICTORS OF RISK FOR DISEASE - An individual at risk for necrotizing enterocolitis and related disorders can be identified by measuring the level of at least one secretor antigen in a biological sample from the individual and comparing the measured level of the at least one secretor antigen to a predetermined value or a predetermined range of values. Among the secretor antigens which can be measured are: the H-1, H-2, Lewis | 03-19-2015 |
| 20150079056 | INFANT CEREAL COMPRISING NON-REPLICATING PROBIOTIC MICROORGANISMS - The present invention relates to the field of infant cereals. In particular, the present invention relates to the field of infant cereals that can be used to strengthen the immune system of the infant and/or that can be used to treat or prevent inflammatory disorders. For example these benefits can be provided by probiotic micro-organisms. An embodiment of the present invention relates to an infant cereal comprising non-replicating probiotic-micro-organisms, for example bioactive heat treated probiotic micro-organisms. | 03-19-2015 |
| 20150098929 | Probiotic Formulation - A probiotic organism which is capable of proliferation in iron-rich media, an environment which is generally unfavourable to probiotic organisms, is described. | 04-09-2015 |
| 20150139968 | PROBIOTIC COMPOSITION FOR TREATING PICORNAVIRUS INFECTION AND ITS USE THEREOF - The present invention relates to a composition used for treating picornavirus infection comprising at least one of the following bacterial strains: | 05-21-2015 |
| 20150290257 | METHOD OF ENHANCING HYALURONIC ACID SECRETION USING PROBIOTIC STRAIN - The present invention provides a method of enhancing hyaluronic acid secretion in a subject, which comprises administrating a composition containing of | 10-15-2015 |
| 20150290262 | PREBIOTICS OF HIGHLY REFINED CELLULOSE - The present technology may include a stabilized mass of highly refined cellulose fiber as a prebiotic composition alone or with a probiotic composition. The prebiotic composition may comprise both the prebiotic material blended with and stabilized by highly refined cellulose fiber material. The prebiotic components may be combined with at least 1% by weight of combined probiotic as highly refined cellulose in a blend with the probiotic. The mass may flow as a liquid, may be in a frozen state or may be in a dried powder state or dried solid mass. | 10-15-2015 |
| 20150297648 | PREBIOTIC COMPOSITIONS COMPRISING ONE OR MORE TYPES OF BACTERIOPHAGE - Disclosed herein are compositions that comprise one or more types of bacteriophage and methods of using such bacteriophages as a prebiotic to promote the growth of beneficial bacteria by decreasing harmful bacterial populations and releasing nutrients into the environment for good bacteria in the digestive system of an individual. | 10-22-2015 |
